Open Nav

Richard Pither



Richard Pither has been involved in the development of diagnostic and therapeutic pharmaceutical products for more than 20 years. He has held senior R&D and leadership positions in global pharmaceutical companies including GE Healthcare (Medical Diagnostics), UCB-Celltech, Lorantis and Amersham plc. During this time, he was involved in the development of a novel 18F-PET radiopharmaceutical for imaging amyloid deposition in the brains of Alzheimer’s disease patients. Richard has led Cytox for the past 7 years, in which time significant technical progress has been made and early revenues from Pharma and Academic customers achieved.

This speaker's sessions:

  • Cytox Ltd
  • Wednesday, October 17
  • 3:45 PM - 4:00 PM